Literature DB >> 7899509

Action spectrum for erythema in humans investigated with dye lasers.

A Anders1, H J Altheide, M Knälmann, H Tronnier.   

Abstract

Erythema reactions of human skin were reevaluated with improved experimental methods: a tunable, highly monochromatic irradiation source as well as an instrumental measurement of skin reactions were used. The irradiation system consisted of an excimer laser pumped dye laser and a UV fiber optic system. The skin color after irradiation was determined with a colorimeter in the three-dimensional norm system of the Commission Internationale d'Eclairage (CIE). The wavelength dependence for delayed erythema was investigated in the UVB and UVA region from 294 nm to 374 nm in skin type II and III individuals. The maximum of the action spectrum in the UVB range was measured at 298.5 nm and an additional maximum was found at 362 nm in the UVA range. The action spectrum is compared with previous spectra from the literature and with the current standard erythema curve of the CIE as well as with other photobiological action spectra. Our results suggest a UVA/UVB boundary at 330 nm.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7899509     DOI: 10.1111/j.1751-1097.1995.tb03961.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  3 in total

1.  Preliminary assessment of the risks associated with solar ultraviolet-A exposure.

Authors:  Boyan Petkov; Vito Vitale; Claudio Tomasi; Emanuela Gadaleta; Mauro Mazzola; Christian Lanconelli; Angelo Lupi; Maurizio Busetto; Elena Benedetti
Journal:  Radiat Environ Biophys       Date:  2010-09-28       Impact factor: 1.925

Review 2.  UV "Indices"-What Do They Indicate?

Authors:  Hanns Moshammer; Stana Simic; Daniela Haluza
Journal:  Int J Environ Res Public Health       Date:  2016-10-24       Impact factor: 3.390

3.  Photobiological Effects at Earth's Surface Following a 50 pc Supernova.

Authors:  Brian C Thomas
Journal:  Astrobiology       Date:  2017-12-28       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.